Why does colorectal cancer defy the rules of the immune system? In most cancers, more regulatory T cells (Tregs) mean a worse outcome — but in colon cancer, it's the opposite. A groundbreaking study from Memorial Sloan Kettering reveals the reason: there are two types of Treg cells, and one actually helps fight the tumor.<br /><br />The research uncovers a key marker, CCR8, found on the harmful Tregs — opening the door to new, highly selective cancer therapies that could finally make immunotherapy effective for the majority of colorectal cancer patients.<br /><br />Even better? This discovery could apply to other cancers like those in the skin, mouth, and stomach.<br /><br />Watch the full video to learn how this game-changing science could save lives.<br />WooGlobe Ref : WGA448567<br />For licensing and to use this video, please email licensing@wooglobe.com
